SARS-CoV-2 Vaccination in the Context of Ongoing HIV Cure-Related Research Studies
- Peluso, M.J.
- Dee, L.
- Taylor, J.
- Campbell, D.M.
- Ehm, A.
- Agosto-Rosario, M.
- Shao, S.
- Williams, M.C.
- Hoh, R.
- Rutishauser, R.L.
- Deeks, S.G.
- Sauceda, J.A.
- Dubé, K.
DOIAbstract
To the Editors: The SARS-CoV-2 pandemic has affected research efforts worldwide. Previously, we described our strategy to mitigate COVID-19 transmission risk during an ongoing HIV cure-related clinical trial. SARS-CoV-2 vaccines recently have been authorized for emergency use and will become available to people with HIV imminently. As a result, researchers must determine how to adjust study protocols to incorporate the likelihood that participants may be vaccinated
Add to ORKG